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Background: The purpose of this study was to determine 
whether either regional anesthesia (RA) or general anesthesia 
(GA) provided the best analgesia with the fewest adverse effects 
up to 2 weeks after ambulatory hand surgery. 
Methods: Patients undergoing ambulatory hand surgery were 
randomly assigned to RA (axillary brachial plexus block; n = 
50) or GA (n = 50). Before surgery, all patients rated their hand 
pain (visual analog scale) and pain-related disability (Pain-Dis-
ability Index). After surgery, eligibility for bypassing the post-
anesthesia care unit ("fast track") was determined, and pain, 
adverse effects, and home-readiness scores were measured. On 
postoperative days 1, 7, and 14, patients documented their pain, 
opioid consumption, adverse effects, Pain-Disability Index, and 
satisfaction. 
Results: More RA patients were fast-track eligible (P < 0.001), 
whereas duration of stay in the postanesthesia care unit was 
shorter in the RA group (P < 0.001). Time to first analgesic 
request was longer in the RA group (P < 0.001), and opioid 
consumption was reduced before discharge (P < 0.001). In the 
RA group, the pain ratings measured at 30, 60, 90, and 120 min 
after surgery were lower (P < 0.001), and patients spent less 
time in the hospital after surgery (P < 0.001). More GA patients 
experienced nausea/ vomiting during recovery in the hospital 
(P < 0.05). However, on postoperative days 1, 7, and 14, there 
were no differences in pain, opioid consumption, adverse ef-
fects, Pain-Disability Index, or satisfaction. 
Conclusions: Despite significant reduction in pain before dis-
charge from the hospital after ambulatory hand surgery, single-
shot axillary brachial plexus block does not reduce pain at 
home on postoperative day 1 or up to 14 days after surgery 
when compared with GA. However, RA does provide other 
significant early benefits, including reduction in nausea and 
faster discharge from the hospitaL 
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BOTH regional anesthesia (RA) and general anesthesia 
(GA) are commonly performed for ambulatory hand sur-
gery. Existing nonrandomized prospective and retro-
spective data show that RA offers several advantages 
compared with GA during recovery in the hospital after 
ambulatory hand surgery, including a reduction in opi-
oid and antiemetic consumption, shortened duration of 
stay in the postanesthesia care unit (PACU) and day 
surgery unit (DSU), and expedited discharge from the 
hospital.1 Compared with GA for ambulatory surgery of 
the upper limb, RA is associated with reduced surgical2 
and nonsurgical3 intraoperative times, fewer unantici-
pated postoperative hospital admissions, 2•4 and greater 
patient satisfaction. 2 In addition, the complete sensory 
blockade produced by RA techniques may reduce cen-
tral sensitization and may have a preventive analgesic 
benefit. 5•6 
However, modem general anesthetic and analgesic 
techniques have several advantages compared with 
older agents and may negate any advantage of RA. Newer 
short-acting general anesthetic agents produce signifi-
cantly fewer adverse effects, shorter recovery time,7 
reduced hospital costs, and improved patient satisfac-
tion8 compared with older agents. Anesthesiologists are 
more familiar with providing GA compared with RA,9 
and it follows that GA is the most widely used anesthetic 
technique for ambulatory surgery. 10 
Although RA has been associated with improved out-
comes for patients undergoing hand surgery while they 
are in the hospital, less is known about what happens 
after discharge. Cooperation with rehabilitation is impor-
tant for functional success after surgery, 11 and good 
early pain control may facilitate this process.12 
No previous prospective randomized trials exist to 
determine whether RA or GA is superior for patients 
tmdergoing ambulatory surgery of the upper extremity. 
Our hypothesis was that RA, by providing good early 
pain control, would provide patients with better pain 
control and less pain-related disability at 14 days after 
surgery. 
Materials and Methods 
After approval by the University Health Network Re-
search Ethics Board (Toronto, Canada) and written in-
formed consent, we recruited patients with American 
Society of Anesthesiologists grade I-III who were under-
going ambulatory hand surgery to this prospective, ran-
domized, open-label study. Inclusion criteria included
age 18–80 yr, weight 40–100 kg, and surgery duration
greater than 30 min and less then 3 h. Exclusion criteria
were language barrier, contraindication to RA, intoler-
ance to nonsteroidal antiinflammatory drugs, asthma,
bleeding diathesis, long-term opioid use, psychiatric his-
tory, and pregnancy.
Each patient’s medical history and preoperative daily
medication consumption were recorded, and all patients
rated the intensity of pain in their hand (operative side)
using a 100-mm visual analog scale (VAS). In addition, all
patients completed the Pain-Disability Index (PDI)13 as a
preoperative measure of disability due to pain in their
hand (operative side). The PDI is a valid self-reported
instrument that determines the extent to which pain
interferes with normal role functioning in seven daily
activities: family/home responsibilities, recreation, social
activity, occupation, sexual behavior, self-care, and life-
support activity.
Using a computer-generated randomization table, pa-
tients were allocated to receive either RA or GA imme-
diately before surgery. Patients allocated to RA were
taken to the regional block room for peripheral nerve
blockade and subsequently transferred to the operating
room (OR), whereas those allocated to GA were taken
directly to the OR. Standard monitors were applied to all
patients, including noninvasive blood pressure monitor,
electrocardiograph, and pulse oximeter, and intravenous
access was secured on the nonoperative side for com-
mencement of a 0.9% saline infusion. All patients re-
ceived intravenous midazolam, 0.03 mg/kg, and ketoro-
lac, 15 mg, before induction of anesthesia.
Patients randomized to RA received a transarterial ax-
illary brachial plexus block performed by a skilled anes-
thesiologist or directly supervised delegate. On the op-
erative side, the shoulder was abducted, and the elbow
was flexed to 90°. The axilla was prepared using an
aseptic technique, and the axillary artery was palpated. A
subcutaneous injection of 2% lidocaine, 1 ml, provided
anesthesia to skin. A 1-in, 23-gauge, noninsulated, long-
beveled needle (PrecisionGlide; Becton Dickinson,
Franklin Lakes, NJ) was then introduced, and on confir-
mation of needle tip placement immediately posterior to
the axillary artery (by negative aspiration of blood), 1.5%
lidocaine, 10 mg/kg, with 1:200,000 epinephrine was
injected incrementally. The time at which the anesthe-
siologist attended the patient, the needle–skin puncture,
the time at injection, and the time of onset of surgical
anesthesia were all recorded. In addition, the number of
needle–skin punctures (i.e., attempts), duration of nee-
dle–skin penetration, incidence of transient paresthesiae
on RA administration, and any other complications, in-
cluding pain on injection of the local anesthetic, were
noted. Supplementary peripheral nerve blocks at the
elbow or wrist were not performed.
Surgical anesthesia at the operative site was deter-
mined immediately before incision. Inadequate anesthe-
sia was defined as pain on pinch in the surgical site using
Allis forceps. In the event of inadequate anesthesia, a
standardized algorithm was followed (standard of prac-
tice in our institution): The surgeon first infiltrated the
surgical site with 1–2% lidocaine or 0.25–0.5% bupiva-
caine. Fentanyl, 25 g, could also be administered every
5 min up to a maximum of 100 g/h. Patients who had
inadequate analgesia despite these measures switched to
GA. Inadequate anxiolysis was treated by administration
of 10–20 mg propofol every 5 min as required.
The quality of the RA was recorded as follows: (1)
adequate: no supplemental analgesic or sedation re-
quired for surgery to proceed within a 30-min period
from institution of axillary block; (2) inadequate: supple-
mental analgesic, sedation, or both required for surgery;
or (3) failed: GA required for surgery. Patients in the RA
group who required GA because of inadequate analgesia,
anxiolysis, or both were assessed in the final analysis as
part of the RA group (intention-to-treat analysis).
General anesthesia comprised a standardized intrave-
nous regimen including 2–3 mg/kg propofol and 2 g/kg
fentanyl. A laryngeal mask airway or endotracheal tube
was used for airway management during surgery. Pa-
tients who required tracheal intubation were paralyzed
with 0.6 mg/kg rocuronium. Maintenance of GA was
provided with a 50:50 mixture of oxygen and nitrous
oxide and 2–6% desflurane. Muscle relaxation was an-
tagonized with 50 g/kg neostigmine and 5–10 g/kg
glycopyrrolate if necessary.
All patients had an upper arm tourniquet applied and
inflated to 100 mmHg above their systolic blood pres-
sure (minimum 200 mmHg). Both the tourniquet pres-
sure and the duration of tourniquet inflation were
recorded.
During postoperative recovery in the hospital, pain
(VAS pain score of  40 mm or patient request for
analgesic) was treated with 25-g fentanyl increments
every 5 min. When oral fluid intake was initiated, pa-
tients received one of two oral analgesic preparations as
needed: Tylenol #3 (300 mg acetaminophen–30 mg co-
deine–15 mg caffeine per tablet; McNeil Consumer
Healthcare, Guelph, Ontario, Canada) or 325 mg acet-
aminophen–5 mg oxycodone HCl per tablet if intolerant
to codeine.
At the time of discharge from the hospital, patients
received a further prescription for Tylenol #3 or 325 mg
acetaminophen–5 mg oxycodone HCl and were in-
structed to take 1–2 tablets every 4 h as required for pain
up to a maximum of 12 tablets/day.
Intraoperatively, the anesthesia induction time, total
surgical time, total tourniquet time, and total anesthesia
time were recorded. On termination of surgery and an-
esthesia in the OR, fast-track eligibility using the Modi-
fied Aldrete score14 was determined. The Modified Al-
drete score rates patient activity, respiration, circulation,
consciousness, and oxygen saturation as a measure of
discharge readiness from the PACU to the DSU but has
recently been used as a surrogate measure of eligibility to
bypass the PACU, i.e., “fast tracking.”15 At 30-min inter-
vals postoperatively, VAS pain scores and Post-Anesthe-
sia Discharge Scoring System home-readiness scores
were collected by an unblinded research assistant.
The Post-Anesthesia Discharge Scoring System16 is a
valid and reliable cumulative index designed to assess
eligibility for discharge home after surgery and anesthe-
sia. Durations of stay in the PACU (PACU recovery time)
and DSU (DSU recovery time) were also recorded.
At the time of discharge from hospital, patients were
given a home diary to complete and return by mail. On
postoperative days (PODs) 1, 7, and 14, patients were
instructed to document their VAS pain score, daily and
cumulative oral analgesic consumption since discharge
from the hospital, incidence of nausea or vomiting, in-
cidence of weakness in the operative arm, incidence of
paresthesiae (numbness or tingling) in the operative
arm, and current VAS satisfaction with anesthetic care.
Finally, patients were also instructed to repeat the PDI
on POD 14. All patients received telephone calls on days
1, 7, and 14 to remind them to complete and return the
diary.
The doses of oral codeine or oxycodone consumed by
each patient were converted into equianalgesic doses of
oral morphine sulfate to facilitate comparison between
both groups. Equianalgesic conversion ratios were used
according to the general monograph for opioids in the
Canadian Pharmacists Association Compendium of Phar-
maceuticals and Specialties17 as follows: oral oxycodone:
oral morphine sulfate  1:2, and oral codeine:oral mor-
phine sulfate  3.3:1.
Statistics
Data were analyzed by intention-to-treat using SPSS®
version 10.0 software (SPSS Inc., Chicago, IL). Normally
distributed continuous data were analyzed using the
unpaired Student t test. Nonnormally distributed data
were analyzed using the Mann–Whitney U test. Differ-
ences in proportions were compared by chi-square test.
All repeated variables were corrected using the Bonfer-
roni method. Significance was considered at P  0.05.
Sample Size Estimation
We defined our primary outcome as pain intensity
(measured by VAS) on POD 14 after ambulatory hand
surgery. Because there were no previous data regarding
pain intensity 2 weeks after hand surgery, we calculated
a sample size of 100 patients (50 per group) using the
Cohen d and a medium effect size correlation (SPSS®
SamplePower, version 1.0) with a type I error rate of
0.05 and power of 0.80. A sample size of 100 patients
also ensured adequate power to detect a difference in
pain intensity between the RA and GA groups on POD 1.
This was based on data from a previous randomized trial
comparing interscalene brachial plexus block to placebo
for adjunctive postoperative analgesia after ambulatory
shoulder surgery.18 We anticipated that mean VAS pain
scores on POD 1 after ambulatory hand surgery would
be 20 and 40 mm for the RA and GA groups, respec-
tively, with an SD of 30 mm. To detect a 20% difference
in VAS pain scores on POD 1 with a type I error rate of
0.01 and a power of 0.80, we calculated that 60 patients
(30/group) would be required.
Results
Preoperatively on the day of surgery, we approached
212 patients in the DSU to recruit and obtain consent for
the current study. Eighty-five patients did not meet in-
clusion criteria for the following reasons: refusal to par-
ticipate, 69 patients; language barrier, 6; weight  100
kg, 2; medication intolerance/allergy, 2; age  18 yr, 2;
long-term opioid use, 2; psychiatric disease, 1; and par-
ticipation in another clinical trial, 1. Twenty-seven pa-
tients gave consent and were randomized but were sub-
sequently excluded for the following reasons:
anesthesiologist favored RA, 11 patients; lost to follow-
up, 9; full stomach, 3; surgery canceled, 2; withdrawal of
consent, 1; and intraarticular steroid injection during
surgery, 1. A total of 100 patients complied with the
protocol and completed the study.
Patient characteristics (except weight), medical his-
tory, American Society of Anesthesiologists physical sta-
tus, preoperative VAS and PDI scores, surgeon, and types
of hand surgery did not differ between the RA and GA
groups (table 1). Procedure types included tendon and
nerve repair, fracture fixation and arthrodesis, digital
amputation, and hardware removal.
There was no difference in intraoperative tourniquet
pressure (RA, 245.0  35.3 mmHg; GA, 245.0 
35.3 mmHg; P  1.000) or duration of tourniquet infla-
tion (RA, 44.6  20.3 min; GA, 51.6  22.4 min; P 
0.103) between groups. During RA administration, the
median amount of needle–skin punctures (i.e., attempts)
was 1/patient (range, 1–7). Needle–skin penetration
lasted 7.7  5.8 min/patient. Although transient pares-
thesiae occurred in 33 patients, no patients reported
intense pain on injection of local anesthetic suggestive of
intraneural injection. Inadequate RA was recorded in 14
patients, of whom all required intraoperative local anes-
thetic infiltration by the surgeon (mean dose of lidocaine
in 5 patients, 77.1  26.9 mg; mean dose of bupivacaine
in 9 patients, 35.0  26.9 mg), 11 required intraopera-
tive fentanyl supplementation (mean dose, 59.1 
16.9 g), and 7 required intraoperative propofol (mean
dose, 144.3  137.8 mg). Five patients (10%) random-
ized to RA required conversion to GA because of block
failure.
Of the 50 patients randomized to GA, 44 patients were
treated with a laryngeal mask airway, whereas 6 required
tracheal intubation for airway management.
The anesthesia time (time from which the anesthesiol-
ogist attended the patient to time at which patient care
was transferred in PACU) was shorter in the GA group
(RA, 112.3 27.3 min; GA, 92.6 25.9 min; P 0.001)
primarily because in the RA group this included the time
spent instituting RA in the regional block room before
entering the OR. The duration of surgical time was sim-
ilar between groups (RA, 54.4  23.1 min; GA, 62.0 
24.4 min; P  0.111); however, the total (surgical plus
anesthesia) time in the OR was significantly shorter in
the RA group (RA, 71.3  22.9 min; GA, 90.0  25.7
min; P 0.001). Upper airway obstruction developed in
one patient in the GA group after extubation of the
airway, and the patient was admitted to hospital over-
night for observation.
After surgery, more RA patients (RA, 49; GA, 27; P 
0.001) were fast-track eligible, and PACU recovery time
was shorter in the RA group (RA, 34.5  22.7 min; GA,
73.2  31.0 min; P  0.001). Although there were no
differences in DSU time between groups (RA, 65.9  43
min; GA, 68.7  33.4 min; P  0.7) if the time spent
both in PACU and DSU are combined the RA patients
spent significantly less time in the hospital before dis-
charge after leaving the OR (RA, 100.4  45.6 min; GA,
142.6  49 min; P  0.001).
In addition, more RA patients achieved home-readiness
criteria at 30 min (RA, 49; GA, 36; P  0.01) and 90 min
(RA, 50; GA, 44; P  0.05) postoperatively, but there
was no statistical difference at 60 min (RA, 49; GA, 43;
P  0.12) or 120 min (RA, 50; GA, 46; P  0.16).
During in-hospital recovery, the time to first analgesic
requirement was longer in the RA group (RA, 97.6 
50.2 min; GA, 29.9  22.8 min; P  0.001). Fentanyl
consumption (RA, 7.0  22.0 g; GA, 77.5  50.3 g;
P  0.001), oral morphine equivalent consumption (RA,
7.3  15.2 mg; GA, 22.8  18.1 mg; P  0.01) (table 2),
and VAS pain scores (fig. 1) were lower in the RA group.
A greater number of GA patients (GA, 12; RA, 3; P 
0.05) experienced nausea, vomiting, or both requiring
antiemetics during recovery in the hospital. Two of the
three RA patients who required antiemetics for nausea,
vomiting, or both in the hospital had undergone conver-
sion to GA for a failed brachial plexus block.
On PODs 1, 7, and 14, there were no differences in
pain (fig. 1) or satisfaction scores or in daily or cumula-
tive oral morphine equivalent consumption (table 2). All
patients reported moderate pain on PODs 1 and 7 (fig.
1). The incidence of nausea or vomiting did not differ
between groups on PODs 1, 7, and 14. There was no
Table 1. Patient Characteristics
RA Group (n  50) GA Group (n  50) Significance, P Value
Age, yr* 42.5 (16) 44.7 (14.3) 0.48
Sex, M/F 28/22 34/16 0.2
Weight, kg 74.3 (15.7) 80.8 (16.9) 0.048
ASA, I/II/III 22/26/2 19/28/3 0.8
Preoperative VAS* 23.4 (27.4) 33 (29.9) 0.1
Preoperative PDI† 27.5 (0–51) 32 (0–57) 0.3
Surgical duration, min* 54.4 (23.1) 62.0 (24.4) 0.1
Tourniquet time, min* 44.6 (20.3) 51.6 (22.4) 0.1
Tourniquet pressure, mmHg* 245 (35.3) 245 (35.3) 1.0
* Data presented as mean (SD). † Data presented as median (range).
ASA  American Society of Anesthesiologists (physical status); GA  general anesthesia; PDI  Pain-Disability Index; RA  regional anesthesia; VAS  visual
analog scale.
Table 2. Postoperative Analgesic Consumption and Adverse Effects
RA Group (n  50) GA Group (n  50) Significance, P Value
Time to first analgesic request, min* 97.6 (50.2) 29.9 (22.8)  0.001
Intravenous fentanyl in PACU, g* 7 (22) 77.5 (50.3)  0.001
Oral morphine equivalent in PACU
and DSU, mg*
7.3 (15.2) 22.8 (18.1)  0.01
Nausea and vomiting in PACU/DSU,
No. of patients
3† 12  0.05
Analgesic consumption POD 1, mg
oral morphine*
42.1 (35.1) 53.3 (47.9) 0.2
Analgesic consumption POD 7, mg
oral morphine*
20.6 (31.4) 21.5 (43.3) 0.9
Analgesic consumption POD 14, mg
oral morphine*
13.2 (22.3) 12.3 (26.5) 0.9
* Data presented as mean (SD). † Two patients received general anesthesia (GA) for regional block failure.
DSU  day surgery unit; PACU  postanesthesia care unit; POD  postoperative day; RA  regional anesthesia.
difference in PDI scores on POD 14. Both groups re-
ported equally high satisfaction scores on PODs 1, 7, and
14 regarding the type of anesthetic they received for
their hand surgery.
The incidence of postoperative paresthesiae in RA pa-
tients at 2 weeks postoperatively was not associated
with the number of needle–skin punctures (P  0.875),
duration of needle–skin penetration (P  0.922), or
occurrence of transient paresthesiae (P  0.465) on RA
administration. The incidence of reported paresthesiae
was similar in both groups at 2 weeks (GA, 22; RA, 20;
P  0.44).
Discussion
This is the first prospective randomized controlled
study comparing RA against GA for hand surgery. We did
not confirm our hypothesis that the improved early pain
control with RA would confer analgesic benefits up to 14
days after surgery. In fact, both groups had moderate
pain both at 24 h and 7 days after surgery, indicating that
patients have significant pain at home after ambulatory
hand surgery. The failure to demonstrate a preventive
analgesic benefit5 is probably because central sensitiza-
tion occurred in both groups after the anesthetic effect
had receded, especially in the first few days after sur-
gery, when moderate pain was experienced. This may
have been different had we used a long-acting local
anesthetic or local anesthetic infusion to prolong pain
control into POD 1. However, recent studies indicate
that the use of local anesthetics alone to produce pre-
ventive analgesia has disappointing results.19 Although
both groups did receive ketorolac before surgery,
greater efforts to reduce central sensitization, such as the
use of an N-methyl-D-aspartate receptor antagonist,20
may have been more successful in reducing pain in the
days and weeks after surgery.
Despite our disappointing results with regard to pain
control after discharge, we have demonstrated that bra-
chial plexus block provides a significantly better quality
of recovery in comparison to GA. Patients who under-
went RA benefited from superior postoperative pain
control with decreased adverse effects that facilitated
fast-track eligibility and hospital discharge after ambula-
tory hand surgery compared with GA.
In contrast to existing retrospective data supporting
improved satisfaction rates in patients who receive RA
compared with GA for ambulatory upper extremity sur-
gery,2 our results suggest equally high satisfaction scores
for patients in both groups. The high satisfaction scores
observed in the GA group may well reflect the minimal
side effect profile of the general anesthetic agents used
in the current study. However, patient satisfaction with
anesthesia may be influenced by many other factors that
occur in the perioperative period.21
By decreasing the duration of time the patient spends
in the OR and the PACU, we can reduce perioperative
costs.1 The current study demonstrates that RA signifi-
cantly shortens time in both the OR and the PACU
compared with GA. The most likely reason for the short-
ened total intraoperative time observed in the RA group
is that brachial plexus blockade was performed outside
the OR in a separate regional block room. Longer anes-
thesia times were observed in RA patients, but the costs
of valuable OR time were spared and efficiency was
maximized because the patients had an anesthetized
limb and were ready for surgery as soon as they were
transferred to the OR. This time efficiency could, at best,
lead to the ability to perform more cases per day or at
least avoid the cancellation of cases due to delay in the
OR. However, the use of a separate block room has cost
implications in itself that may outweigh any benefit
gained from the reduced OR time.22
We demonstrated that with RA, patients spent signifi-
cantly less time in the hospital and were discharged
significantly earlier after surgery then with GA (P 
0.001), primarily because of a reduction in PACU time.
Patients in the GA group had greater pain, required
significantly more analgesics while in the hospital, and
experienced greater nausea. However, there was actu-
ally no difference between groups in terms of time spent
in the DSU, despite the overall reduced time spent in the
hospital after surgery in the RA group. Time spent in the
DSU is affected by numerous confounding factors, such
as dressing the patient and the availability of patient
chaperones and transport,7 and this may have resulted in
our inability to demonstrate a reduction in DSU time in
the RA group.
The most recent American Society of Anesthesiologists
Closed Claims database analysis in 1999 revealed that the
use of RA is more frequently associated with claims
involving nerve damage compared with GA,23 but the
mechanism of nerve injury has yet to be defined. RA may
cause nerve injury by way of direct needle trauma, local
anesthetic toxicity, or pressure-induced ischemia. Alter-
natively, nerve injury may be unrelated to RA and due to
patient position, prolonged tourniquet inflation, or sur-
gical technique. Nevertheless, many anesthesiologists do
not provide RA for fear of medicolegal action stemming
Fig. 1. Visual analog scale (VAS) scores in the hospital and at
home up to postoperative day (POD) 14. VAS rating of pain
intensity (y-axis) versus time (x-axis). GA  general anesthesia;
RA  regional anesthesia.
from nerve damage.24 Despite widely held beliefs that
RA causes nerve damage more readily than GA, there
have been no randomized trials comparing adverse post-
operative neurologic outcome in patients receiving RA
versus GA for upper extremity surgery. The current
study demonstrates that, although the incidence of post-
operative paresthesiae is surprisingly high in all patients
after ambulatory hand surgery, there is no difference in
neurologic symptoms between RA and GA groups up to
2 weeks after surgery. These data tell us nothing about
the cause of the neurologic symptoms, but they do tell
us that neurologic symptoms are common after hand
surgery and that all potential causes of such symptoms
should be explored before apportioning blame.25
This study has a number of limitations, including use of
an open-label technique; a short-acting local anesthetic
agent; and a single-shot, single-endpoint brachial plexus
block technique.
Although all data in the hospital were collected by an
unblinded research assistant, it would have been ex-
tremely difficult to blind a research assistant to a patient
recovering from RA compared with GA. However, the
validated scoring systems used for data collection in the
hospital (such as Aldrete and Post-Anesthesia Discharge
Scoring System) may reduce the potential for introduc-
tion of bias. All data recorded at home were by patient
self-report in a diary, without contact with any member
of the research team. Telephone calls were made to
remind patients to complete the diary, but no assistance
was given with completion.
Although single-endpoint axillary block techniques are
associated with a lower success rate then multiple-end-
point techniques,26 we wanted to use a technique that is
commonly used and therefore able to be generalized to
a wider population. Certainly the block failure rate ob-
served in this study could be improved with the use of a
multiple-endpoint technique. However, transarterial ax-
illary brachial plexus blockade has an easily recognizable
endpoint and is easy to teach and learn. For this reason,
it is the preferred axillary technique taught at our insti-
tution for ambulatory hand surgery given the record of
success and safety with which it is associated.27
Lidocaine, 1.5% (10 mg/kg), is our local anesthetic
agent of choice for axillary brachial plexus blockade in
patients undergoing ambulatory hand surgery because of
its rapid onset, but it is limited by a short duration of
action. The use of a longer-acting agent may have ex-
tended duration of analgesia into the first POD.
Future Directions
Efforts should be directed at reducing the pain expe-
rienced by patients in the early postoperative period at
home after ambulatory hand surgery. Improved patient
education could provide a simple but beneficial inter-
vention. Prolongation of analgesia with multimodal tech-
niques28 such as the use of controlled-release opioids,29
nonsteroidal antiinflammatory agents, or both could pro-
vide benefit. Recently evaluated techniques such as pa-
tient-controlled RA that enable continuous axillary bra-
chial plexus blockade at home30 may help to reduce the
moderate pain that patients experience during the first
week after ambulatory hand surgery.
Summary
In conclusion, RA when compared with GA did not
result in better pain control at home up to 14 days
following ambulatory hand surgery. However RA did
provide improved early pain control with less adverse
effects and faster hospital discharge.
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